Werbung
Eagle Pharmaceuticals Aktie Analyse
| 01.11.18 | Eagle Pharmaceuticals Neutral | Cantor Fitzgerald | |
| 21.03.18 | Eagle Pharmaceuticals Underperform | Mizuho | |
| 09.11.17 | Eagle Pharmaceuticals Outperform | RBC Capital Markets | |
| 06.09.17 | Eagle Pharmaceuticals Underperform | Mizuho | |
| 27.07.17 | Eagle Pharmaceuticals Outperform | RBC Capital Markets | |
| 27.07.17 | Eagle Pharmaceuticals Underperform | Mizuho | |
| 09.05.17 | Eagle Pharmaceuticals Outperform | RBC Capital Markets | |
| 09.01.17 | Eagle Pharmaceuticals Underperform | Mizuho | |
|
Werbung
|
|||
| 16.11.16 | Eagle Pharmaceuticals Neutral | Mizuho | |
| 03.11.16 | Eagle Pharmaceuticals Outperform | RBC Capital Markets | |
| 03.11.16 | Eagle Pharmaceuticals Buy | Mizuho | |
| 26.10.16 | Eagle Pharmaceuticals Buy | Mizuho | |
| 20.06.16 | Eagle Pharmaceuticals Neutral | Mizuho | |
| 10.05.16 | Eagle Pharmaceuticals Outperform | RBC Capital Markets | |
| 18.03.16 | Eagle Pharmaceuticals Buy | Mizuho | |
| 26.02.16 | Eagle Pharmaceuticals Buy | Mizuho | |
| 09.12.15 | Eagle Pharmaceuticals Buy | Mizuho | |
Werbung
Werbung